Patients with mild-to-moderate COVID-19 have activated CD4+ and CD8+ T cells, increased antibody-producing cells and follicular helper T cells, as well as IgM and IgG antibodies in blood prior to symptomatic recovery [57]. This evidence concerns the gene CD40LG and COVID-19.